Valuation: Edwards Lifesciences Corporation

Market Cap 47.58B 41.79B 38.86B 35.66B 67B 4,582B 68.04B 461B 180B 2,253B 179B 175B 7,788B P/E 2026 *
31.7x
P/E 2027 * 25.1x
Enterprise Value 43.91B 38.56B 35.86B 32.91B 61.83B 4,228B 62.79B 426B 166B 2,079B 165B 161B 7,187B EV / Sales 2026 *
6.5x
EV / Sales 2027 * 5.71x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week-3.62%
Current month-8.66%
1 month-8.98%
3 months-1.81%
6 months-1.95%
Current year-3.07%
1 week 82.53
Extreme 82.53
89.08
1 month 82.53
Extreme 82.53
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 10/05/2023
Director of Finance/CFO 43 28/05/2026
Chief Tech/Sci/R&D Officer 51 31/08/2025
Director TitleAgeSince
Chairman 69 06/05/2024
Director/Board Member 62 09/02/2015
Director/Board Member 58 10/05/2023
Date Insider Type Main position Quantity % Market Cap.
11/07/26 Tax

Executive/Senior Manager

-109 0.0000%
10/07/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
09/07/26 Free

Chief Financial Officer

174,045 0.0302%
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%-3.62%+3.29%-9.82% 47.58B
-0.71%+6.72%+18.80%-1.07% 211B
-0.52%-6.05%-6.80%-27.70% 135B
+1.65%-2.29%-31.94%+2.47% 119B
+1.54%+0.50%-58.31%-15.55% 65.77B
+3.03%-0.17%-26.91%-32.63% 44.44B
-0.84%+5.41%+15.30%+7.86% 39.14B
-2.02%+1.54%+23.68%+29.24% 36.79B
-1.41%+3.99%+77.58%+1.52% 29.37B
+1.76%-1.87%-29.03%-11.89% 28.17B
Average +0.11%+0.42%-1.44%-5.76% 75.63B
Weighted average by Cap. +0.06%+0.68%-3.57%-7.28%

Financials

2026 *2027 *
Net sales 6.76B 5.93B 5.52B 5.06B 9.51B 651B 9.66B 65.52B 25.6B 320B 25.36B 24.81B 1,106B 7.42B 6.52B 6.06B 5.56B 10.45B 715B 10.61B 72B 28.13B 351B 27.87B 27.26B 1,215B
Net income 1.49B 1.31B 1.22B 1.12B 2.1B 143B 2.13B 14.44B 5.64B 70.48B 5.59B 5.47B 244B 1.9B 1.66B 1.55B 1.42B 2.67B 183B 2.71B 18.38B 7.18B 89.74B 7.12B 6.96B 310B
Net Debt -3.67B -3.23B -3B -2.75B -5.17B -354B -5.25B -35.62B -13.92B -174B -13.79B -13.49B -601B -5.17B -4.54B -4.22B -3.87B -7.28B -498B -7.39B -50.14B -19.59B -245B -19.41B -18.99B -846B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
24/07/26 US$82.63 -1.42% 10,480,908
23/07/26 US$83.82 -0.65% 6,913,372
22/07/26 US$84.37 -0.21% 4,512,283
21/07/26 US$84.55 -0.53% 5,571,029
20/07/26 US$85.00 -0.85% 3,751,422
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
82.63USD
Average target price
100.48USD
Spread / Average Target
+21.60%

Quarterly revenue - Rate of surprise